← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:976 | 976 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:976 | 976 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0863 | 5446-0863-01 | Lidocaine; Racepinephrine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:976 | 976 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0408 | 72196-0408-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:976 | 976 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0301 | 71285-0301-1 | Magnesium Sulfate Heptahydrate; Dextrose Monohydrate; Trisodium Citrate Dihydrate; Sodium Chloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:976 | 976 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Prilocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:976 | 976 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-5114 | 73271-5114-1 | Lidocaine; Prilocaine; Tetracaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:976 | 976 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-501 | 65302-501-03 | Neostigmine Methylsulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:976 | 976 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-126 | 73177-126-01 | Neostigmine | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:976 | 976 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-022 | 71449-022-32 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:976 | 976 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6412 | 71266-6412-3 | Mitomycin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:976 | 976 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1321 | 72934-1321-2 | Niacinamide; Dapsone | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:976 | 976 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ondansetron Hydrochloride; Ketamine Hydrochloride; Midazolam | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:976 | 976 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6043 | 71285-6043-1 | Oxytocin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:976 | 976 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6519 | 71266-6519-1 | Phenol | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:976 | 976 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-023 | 73198-023-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:977 | 977 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0012 | 71139-0012-1 | Oxytocin | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:977 | 977 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:977 | 977 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1268 | 5446-1268-01 | Lidocaine; Racepinephrine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:977 | 977 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0408 | 71285-0408-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:977 | 977 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0215 | 71285-0215-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:977 | 977 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Prilocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:977 | 977 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-6114 | 73271-6114-1 | Lidocaine; Prilocaine; Tetracaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:977 | 977 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-501 | 65302-501-05 | Neostigmine Methylsulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:977 | 977 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-9 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:977 | 977 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-100 | 70004-100-16 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:977 | 977 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-103 | 81375-103-40 | Mitomycin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:977 | 977 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2362 | 72934-2362-2 | Niacinamide; Fluocinolone Acetonide | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:977 | 977 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-164 | 82396-164-05 | Oxycodone Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:977 | 977 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-018 | 72055-018-01 | Oxytocin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:977 | 977 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:977 | 977 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-010 | 73198-010-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:978 | 978 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8200 | 72682-8200-1 | Testosterone 200mg Pellet (Large) | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:978 | 978 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:978 | 978 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1276 | 5446-1276-01 | Lidocaine; Racepinephrine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:978 | 978 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0406 | 71285-0406-1 | Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:978 | 978 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0213 | 71285-0213-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:978 | 978 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Prilocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:978 | 978 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1114 | 73271-1114-1 | Lidocaine; Prilocaine; Tetracaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:978 | 978 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:978 | 978 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-2 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:978 | 978 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-100 | 70004-100-63 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:978 | 978 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-100 | 81375-100-40 | Mitomycin | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:978 | 978 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1400 | 72934-1400-2 | Niacinamide; Ivermectin; Metronidazole | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:978 | 978 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-164 | 82396-164-25 | Oxycodone Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:978 | 978 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:978 | 978 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:978 | 978 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-010 | 73198-010-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:979 | 979 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-026 | 70713-026-01 | PROGESTERONE SA2 100MG | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:979 | 979 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-9010 | 60652-9010-1 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:979 | 979 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0607 | 5446-0607-01 | Lidocaine; Racepinephrine; Tetracaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:979 | 979 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0406 | 72196-0406-1 | Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:979 | 979 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0214 | 71285-0214-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:979 | 979 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1235 | 5446-1235-01 | Lidocaine; Benzocaine; Tetracaine | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:979 | 979 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-3114 | 73271-3114-1 | Lidocaine; Prilocaine; Tetracaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:979 | 979 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:979 | 979 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-1 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:979 | 979 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-100 | 70004-100-62 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:979 | 979 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:979 | 979 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1399 | 72934-1399-2 | Niacinamide; Ivermectin; Metronidazole; Brimonidine Tartrate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:979 | 979 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-164 | 82396-164-13 | Oxycodone Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:979 | 979 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:979 | 979 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:979 | 979 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-025 | 73198-025-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:980 | 980 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-147 | 70092-147-03 | KCl 10 mEq lido 10 mg add 100 ml NS bag | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:980 | 980 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2080 | 71286-2080-1 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:980 | 980 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3102 | 72627-3102-1 | Lidocaine; Tetracaine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:980 | 980 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-988 | 69374-988-10 | Lysine Hydrochloride; Arginine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:980 | 980 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0112 | 72196-0112-1 | Magnesium Sulfate Heptahydrate; Tromethamine; Dextrose Monohydrate; Sodium Chloride; Sodium Gluconate; Magnesium Chloride; Sodium Acetate; Potassium Chloride; Mannitol | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:980 | 980 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3100 | 72627-3100-1 | Lidocaine; Benzocaine; Tetracaine | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:980 | 980 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-4552 | 73271-4552-1 | Lidocaine; Prilocaine; Tetracaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:980 | 980 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:980 | 980 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-125 | 71449-125-11 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:980 | 980 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-100 | 70004-100-59 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:980 | 980 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-01 | Morphine Sulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:980 | 980 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2391 | 72934-2391-2 | Niacinamide; Lactic Acid | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:980 | 980 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:980 | 980 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:980 | 980 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:980 | 980 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-025 | 73198-025-05 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:981 | 981 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-520 | 70092-520-49 | Morphine PF 1 mg/ml in 30ml NS- 35 ml MB | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:981 | 981 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2074 | 71286-2074-1 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:981 | 981 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:981 | 981 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine Hydrochloride; Arginine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:981 | 981 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0202 | 72196-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:981 | 981 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3101 | 72627-3101-1 | Lidocaine; Benzocaine; Tetracaine | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:981 | 981 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-8114 | 73271-8114-1 | Lidocaine; Prilocaine; Tetracaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:981 | 981 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1335 | 72934-1335-2 | Niacinamide; Adapalene; Benzoyl Peroxide | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:981 | 981 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-750 | 70004-750-09 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:981 | 981 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-522 | 70092-522-35 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:981 | 981 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-05 | Morphine Sulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:981 | 981 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1341 | 72934-1341-2 | Niacinamide; Levocetirizine Dihydrochloride; Imiquimod | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:981 | 981 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0012 | 71139-0012-1 | Oxytocin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:981 | 981 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:981 | 981 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:981 | 981 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-025 | 73198-025-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:982 | 982 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3720 | 72682-3720-1 | Estradiol 20mg | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:982 | 982 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-4 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:982 | 982 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine; Benzocaine | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:982 | 982 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5105 | 26436-5105-5 | Magnesium Chloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:982 | 982 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0202 | 71285-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:982 | 982 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Benzocaine; Tetracaine | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:982 | 982 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-3552 | 73271-3552-1 | Lidocaine; Prilocaine; Tetracaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:982 | 982 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1338 | 72934-1338-2 | Niacinamide; Diclofenac Sodium | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:982 | 982 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-002 | 72055-002-02 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:982 | 982 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-133 | 70092-133-43 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:982 | 982 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-02 | Morphine Sulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:982 | 982 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1019 | 70657-1019-3 | Niacinamide; Pyridoxine; Thiamine Hydrochloride; Riboflavin 5'-Phosphate Sodium | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:982 | 982 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-004 | 72055-004-01 | Oxytocin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:982 | 982 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-004 | 72055-004-01 | Oxytocin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:982 | 982 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:982 | 982 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:983 | 983 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1338 | 72934-1338-2 | Roaoxia Gel | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:983 | 983 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-5 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:983 | 983 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-021 | 71591-021-01 | Lidocaine; Tetracaine; Benzocaine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:983 | 983 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0225 | 71283-0225-5 | Magnesium Chloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:983 | 983 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0205 | 71285-0205-1 | Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride; Calcium Chloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:983 | 983 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1548 | 5446-1548-01 | Lidocaine; Hyaluronidase; Bupivacaine | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:983 | 983 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-2114 | 73271-2114-1 | Lidocaine; Prilocaine; Tetracaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:983 | 983 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1341 | 72934-1341-2 | Niacinamide; Imiquimod; Levocetirizine Dihydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:983 | 983 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0329 | 60652-0329-1 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:983 | 983 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-125 | 70092-125-48 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:983 | 983 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-04 | Morphine Sulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:983 | 983 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1311 | 72934-1311-2 | Niacinamide; Spironolactone | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:983 | 983 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-018 | 72055-018-01 | Oxytocin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:983 | 983 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-517 | 83298-517-10 | Oxytocin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:983 | 983 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:983 | 983 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:984 | 984 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 54288-827 | 54288-827-25 | Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL) | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:984 | 984 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-6 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:984 | 984 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:984 | 984 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:984 | 984 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0111 | 71285-0111-1 | Mannitol; Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride; Tromethamine; Dextrose Monohydrate; Sodium Acetate; Sodium Gluconate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:984 | 984 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1480 | 5446-1480-01 | Lidocaine; Hyaluronidase; Racepinephrine | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:984 | 984 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0863 | 5446-0863-01 | Lidocaine; Racepinephrine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:984 | 984 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-500 | 71170-500-25 | Norepinephrine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:984 | 984 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-002 | 72055-002-01 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:984 | 984 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-103 | 70004-103-16 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:984 | 984 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-16 | Morphine Sulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:984 | 984 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2318 | 72934-2318-2 | Niacinamide; Tazarotene | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:984 | 984 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-012 | 68985-012-93 | Oxytocin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:984 | 984 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:984 | 984 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:984 | 984 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:985 | 985 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9032 | 83826-9032-5 | Timolol, Dorzolamide, Bimatoprost | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:985 | 985 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-3 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:985 | 985 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0401 | 72196-0401-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:985 | 985 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2431 | 72627-2431-1 | Magnesium Chloride Tetrahydrate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:985 | 985 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0111 | 72196-0111-1 | Mannitol; Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride; Tromethamine; Dextrose Monohydrate; Sodium Acetate; Sodium Gluconate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:985 | 985 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1256 | 5446-1256-01 | Lidocaine; Oxymetazoline Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:985 | 985 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1268 | 5446-1268-01 | Lidocaine; Racepinephrine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:985 | 985 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-319 | 69374-319-25 | Norepinephrine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:985 | 985 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6065 | 71286-6065-1 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:985 | 985 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:985 | 985 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-30 | Morphine Sulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:985 | 985 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Niacinamide; Tretinoin | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:985 | 985 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-517 | 83298-517-10 | Oxytocin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:985 | 985 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:985 | 985 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:985 | 985 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:986 | 986 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-023 | 71449-023-11 | Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:986 | 986 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-2 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:986 | 986 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0412 | 71285-0412-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:986 | 986 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride; Zinc Sulfate; Copper Gluconate; Sodium Selenite; Manganese Sulfate | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:986 | 986 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5409 | 26436-5409-1 | Mebendazole | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:986 | 986 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1118 | 5446-1118-01 | Lidocaine; Phenylephrine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:986 | 986 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0607 | 5446-0607-01 | Lidocaine; Racepinephrine; Tetracaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:986 | 986 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-315 | 69374-315-25 | Norepinephrine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:986 | 986 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-932 | 69374-932-33 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:986 | 986 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:986 | 986 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:986 | 986 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2429 | 72934-2429-2 | Niacinamide; Tretinoin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:986 | 986 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0903 | 83863-0903-1 | Oxytocin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:986 | 986 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:986 | 986 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:986 | 986 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:987 | 987 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5015 | 26436-5015-3 | Methylcobalamin | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:987 | 987 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2081 | 71286-2081-1 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:987 | 987 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0401 | 71285-0401-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:987 | 987 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Hydroxide; Aluminum Hydroxide; Dimethicone; Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:987 | 987 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Mechlorethamine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:987 | 987 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1045 | 5446-1045-03 | Lidocaine; Phenylephrine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:987 | 987 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:987 | 987 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-316 | 69374-316-25 | Norepinephrine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:987 | 987 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-902 | 69374-902-35 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:987 | 987 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:987 | 987 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:987 | 987 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2299 | 72934-2299-4 | Niacinamide; Tretinoin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:987 | 987 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-028 | 71506-028-59 | Oxytocin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:987 | 987 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:987 | 987 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:987 | 987 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:988 | 988 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83155-108 | 83155-108-25 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:988 | 988 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-1 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:988 | 988 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0416 | 71285-0416-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:988 | 988 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Sulfate Heptahydrate | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:988 | 988 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69389-044 | 69389-044-26 | Medroxyprogesterone Acetate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:988 | 988 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5468 | 26436-5468-1 | Lidocaine; Phenylephrine Hydrochloride; Benzocaine; Tetracaine | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:988 | 988 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3102 | 72627-3102-1 | Lidocaine; Tetracaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:988 | 988 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-117 | 73702-117-03 | Norepinephrine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:988 | 988 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-902 | 69374-902-05 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 |